Literature DB >> 6972433

Multiple sclerosis in the Orkney and Shetland Islands. III: Histocompatibility determinants.

D C Poskanzer, P I Terasaki, L B Prenney, J L Sheridan, M S Park.   

Abstract

Histocompatibility testing was performed in 48 multiple sclerosis patients and two carefully matched control groups in Orkney Islands, an area of high multiple sclerosis prevalence. The frequency of HLA-A3, HLA-B7, and DW2 was comparable in patients and controls. However, HLA-B7 was significantly more common in female patients compared with male patients. A B-cell alloantigen (B-cell 4) was also as frequent in patients as among controls. Strong linkage between HLA-B7, DW2 and B-cell 4 occurred in controls, but not patients; the linkage was particularly striking in female controls. These data are not consistent with theories that relate certain of the histocompatibility antigens to the aetiology of multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6972433      PMCID: PMC1052087          DOI: 10.1136/jech.34.4.253

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  15 in total

1.  Immunogenetic analysis and serum viral antibody titers in multiple sclerosis.

Authors:  J N Whitaker; K L Herrmann; G N Rogentine; S F Stein; L L Kollins
Journal:  Arch Neurol       Date:  1976-06

2.  Letter: HL-A antigens in myasthenia gravis.

Authors:  D Fritze; C Herrmann; F Naeim; G S Smith; R L Walford
Journal:  Lancet       Date:  1974-07-06       Impact factor: 79.321

3.  HL-A polymorphism of Norwegian Lapps.

Authors:  E Thorsby; A Bratlie; P Teisberg
Journal:  Tissue Antigens       Date:  1971

4.  Histocompatibility types and measles antibodies in multiple sclerosis and optic neuritis.

Authors:  B G Arnason; T C Fuller; J R Lehrich; S H Wray
Journal:  J Neurol Sci       Date:  1974-08       Impact factor: 3.181

5.  HL-A antigens and diseases. I. Multiple sclerosis.

Authors:  C Jersild; A Svejgaard; T Fog; T Ammitzboll
Journal:  Tissue Antigens       Date:  1973

6.  A semimicro mixed leukocyte culture test.

Authors:  D P Sengar; P I Terasaki
Journal:  Transplantation       Date:  1971-03       Impact factor: 4.939

7.  Histocompatibility determinants in multiple sclerosis.

Authors:  C Jersild; B Dupont; T Fog; P J Platz; A Svejgaard
Journal:  Transplant Rev       Date:  1975

8.  Multiple sclerosis and high incidence of a B lymphocyte antigen.

Authors:  P I Terasaki; M S Park; G Opelz; A Ting
Journal:  Science       Date:  1976-09-24       Impact factor: 47.728

9.  Association of histocompatibility haplotype HLA-A3-B7 with multiple sclerosis.

Authors:  H J Bertrams; E K Kuwert
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

10.  B-lymphocyte alloantigens in Caucasians.

Authors:  A Ting; M R Mickey; P I Terasaki
Journal:  J Exp Med       Date:  1976-04-01       Impact factor: 14.307

View more
  11 in total

Review 1.  HLA and multiple sclerosis in Italy: a review of the literature.

Authors:  L La Mantia; M T Illeni; C Milanese; A Salmaggi; M Eoli; G Pellegris; A Nespolo
Journal:  J Neurol       Date:  1990-11       Impact factor: 4.849

2.  Multiple sclerosis: nature or nurture?

Authors:  D C Skegg
Journal:  BMJ       Date:  1991-02-02

3.  Class II HLA antigens in multiple sclerosis.

Authors:  D H Miller; R W Hornabrook; J Dagger; R Fong
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-05       Impact factor: 10.154

4.  The distribution of multiple sclerosis in the United Kingdom.

Authors:  R J Swingler; D Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-10       Impact factor: 10.154

Review 5.  A review of the etiology of multiple sclerosis.

Authors:  V Vella
Journal:  Ital J Neurol Sci       Date:  1984-12

6.  HLA-linked and unlinked determinants of multiple sclerosis.

Authors:  H Z Ho; J L Tiwari; R W Haile; P I Terasaki; N E Morton
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

7.  Multiple sclerosis in the Orkney and Shetland Islands and in north-east Scotland.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-14

8.  Genome-wide homozygosity and multiple sclerosis in Orkney and Shetland Islanders.

Authors:  Rebekah E McWhirter; Ruth McQuillan; Elizabeth Visser; Carl Counsell; James F Wilson
Journal:  Eur J Hum Genet       Date:  2011-09-07       Impact factor: 4.246

9.  Multiple sclerosis in the Orkney and Shetland Islands. V: The effect on viral titres of histocompatibility determinants.

Authors:  D C Poskanzer; J L Sever; P I Terasaki; L B Prenney; J L Sheridan; M S Park
Journal:  J Epidemiol Community Health       Date:  1980-12       Impact factor: 3.710

10.  The mystery of the origin of multiple sclerosis.

Authors:  W I McDonald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-02       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.